Hematology AI & RWE Strategy Director

PharmaPayWatch; Boston (MA); On-site; USD 156,000 - 233,000; Full time

Benefits offered by this job

Short-term incentive bonuses

Equity-based awards

Retirement programs

Paid time off and health benefits

Job summary

PharmaPayWatch in Boston, MA is seeking a Director, Hematology Clinical Intelligence & RWE Strategy to lead end-to-end evidence strategy across R&D to market access. You will identify evidence gaps and rank strategies that shape portfolio decisions, regulatory filings, and commercial positioning.

You will partner across Translational Science, Clinical Development, and Market Access to leverage multimodal data (genomics, imaging, clinical data) and implement AI-enabled methods for trial

Qualifications

• Advanced degree in epidemiology, biostatistics, health economics or related field.
• 5+ years in evidence generation, RWE, or health outcomes research in pharma/biotech.
• Experience translating analytics into portfolio and evidence strategy.

Responsibilities

• Lead hematology evidence strategy from R&D to patient care and market access.
• Define evidence gaps and prioritize PH3ID-related initiatives.
• Integrate multimodal signals for patient stratification and biomarkers.
• Advance AI-enabled approaches: tumor dynamics, prognostic risk, trial simulation.
• Turn internal/real-world data into insights on standard of care and access decisions.
• Collaborate with global teams and external partners to keep outputs rigorous.
• Build persistent hematology intelligence within PH3ID foundation for reuse.

Skills

Leadership & influence

Translational Science interface

Senior stakeholder influence

Oncology real-world data

Multimodal modeling

Evidence generation methodologies

Education

Advanced degree in epidemiology/biostatistics/health economics/clinical science

5+ years in evidence generation/RWE/health outcomes

Tools

HTA dossiers

Job description

PharmaPayWatch in Boston, MA is seeking a Director, Hematology Clinical Intelligence & RWE Strategy to lead end-to-end evidence strategy across R&D to market access. You will identify evidence gaps and rank strategies that shape portfolio decisions, regulatory filings, and commercial positioning.

You will partner across Translational Science, Clinical Development, and Market Access to leverage multimodal data (genomics, imaging, clinical data) and implement AI-enabled methods for trial